Abstract:It is well-recognized that the activation of the renin-angiotensin system (RAS) and leptin resistance are implicated in the pathogenesis of obesity and type 2 diabetes. Indeed, we have previously demonstrated that the mice lacking the renin (Ren1c-/-) gene are lean and insulin sensitive, which were associated with increased energy expenditure and fecal fat excretion. We further showed that the expression of the suppressor of cytokine signaling 3 (SOCS3), a molecule that contributes to leptin resistance, was significantly decreased in Ren1c-/- mice. In the present study, we tested the hypothesis that genetic deletion of Ren1c or blockade of angiotensin II (Ang II) AT1 receptors improves leptin and insulin sensitivity in mice. To test the hypothesis, male wild-type (WT) and Ren1c-/- mice were infused with or without leptin (100 μg/kg/day, i.p.) for two weeks. Mice were subjected to intraperitoneal glucose tolerance (IPGTT) and insulin tolerance test (IPITT) at basal and after leptin treatment. The expression of p-STAT3 and AMPK was determined by western blot and ELISA. The expression of phosphorylated STAT3 proteins was significantly increased in the hypothalamus of Ren1c-/- mice than in WT mice (P<0.05), while AMPK activity of the hypothalamus was markedly decreased in Ren1c-/- mice (P<0.05). These responses in Ren1c-/- mice were recapitulated by the blockade of AT1 receptors with losartan (0.15 g/L in drinking water) in WT mice. We reasoned that these responses to leptin in Ren1c-/- mice may be due to decreased plasma leptin levels in Ren1c-/- mice. To further test this hypothesis, we generated mice lacking both renin and leptin (Ren1c-/-;ob/ob). Ren1c-/-;ob/ob mice had ~10% lower body weight than ob/ob mice under basal conditions, and their body weight and body fat decreased further in response to leptin infusion. More importantly, the hypothalamus of Ren1c-/-;ob/ob mice had significantly lower SOCS3 and AMPK activity and higher p-STAT3 expression compared to ob/ob mice (P<0.05). Glucose and insulin tolerance were significantly improved in Ren1c-/-;ob/ob mice, compared to ob/ob mice. Blockade of AT1 receptors with losartan also significantly improved IPGTT and IPITT, respectively. Taken together, our results suggest that the RAS plays an important role in both insulin and leptin resistance in obesity and type 2 diabetes, and that genetic deletion of Ren1c or blockade of angiotensin II (Ang II) AT1 receptors improves leptin and insulin sensitivity in ob/ob mice.

Leptin Gene Transfer Improves Symptoms of Type 2 Diabetic Mice by Regulating Leptin Signaling Pathway and Insulin Resistance of Peripheral Tissues.

Induction of Adipocyte Hyperplasia in Subcutaneous Fat Depot Alleviated Type 2 Diabetes Symptoms in Obese Mice.

Leptin Gene Transfer Regulates Fibromuscular Development and Lipid Deposition in Muscles Via SIRT1, FOXO3a and PGC-1α in Mice in Vivo.

Effect of Hepatic Insulin Expression on Lipid Metabolism in Diabetic Mice

Integrated Analysis of Gene Modulation Profile Identifies Pathogenic Factors and Pathways in the Liver of Diabetic Mice.

Leptin Contributes to the Adaptive Responses of Mice to High-Fat Diet Intake Through Suppressing the Lipogenic Pathway.

Genetic Ablation Of The Ren1c And Leptin Genes Improves Insulin And Leptin Sensitivity In Mice

Serum, liver, and kidney proteomic analysis for the alloxan-induced type I diabetic mice after insulin gene transfer of naked plasmid through electroporation.

Tetradecyl 2,3-Dihydroxybenzoate Improves the Symptoms of Diabetic Mice by Modulation of Insulin and Adiponectin Signaling Pathways

Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Hepatic Gene Expression Profiling Reveals Key Pathways Involved in Leptin-Mediated Weight Loss in Ob/ob Mice

Insulin Therapy Stimulates Lipid Synthesis and Improves Endocrine Functions of Adipocytes in Dietary Obese C57BL/6 Mice

Effects of Intracerebroventricular Injection of Leptin on the Expression of Obese Gene in Adipose Tissue and the Level of Serum Leptin and Serum Insulin, C-peptide in Diet-Induced Obese Rats

Protein Tyrosine Phosphatase 1B Deficiency Improves Glucose Homeostasis in Type 1 Diabetes Treated With Leptin

Treatment of Diabetic Mice with a Combination of Ketogenic Diet and Aerobic Exercise Via Modulations of PPARs Gene Programs.

Effects of Exogenous Insulin Intervention on Insulin Signaling Pathway in the Liver of Diabetic Mice YU

Insulin Expression in Livers of Diabetic Mice Mediated by Hydrodynamics-Based Administration

Hepatic Leptin Signaling Improves Hyperglycemia by Stimulating MAPK Phosphatase-3 Protein Degradation Via STAT3.

Increased Carnitine Palmitoyl Transferase 1 Expression and Decreased Sterol Regulatory Element–binding Protein 1c Expression Are Associated with Reduced Intramuscular Triglyceride Accumulation after Insulin Therapy in High-Fat–diet and Streptozotocin-Induced Diabetic Rats

Gene Expression Profile Analysis Of Type 2 Diabetic Mouse Liver

Abstract Mo135: Correlation of Leptin Resistance with Attenuation of Cardiac Vagal Activation in Type 2 Diabetes